CTI BIOPHARMA CORP Quarterly Other Assets, Noncurrent in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Cti Biopharma Corp quarterly Other Assets, Noncurrent history and growth rate from Q2 2010 to Q1 2023.
  • Cti Biopharma Corp Other Assets, Noncurrent for the quarter ending March 31, 2023 was $3.11M, a 5.44% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $3.11M -$179K -5.44% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $3.3M -$576K -14.8% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 $2.77M +$897K +47.8% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $2.87M +$636K +28.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $3.29M +$505K +18.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $3.88M +$682K +21.3% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $1.88M -$1.69M -47.4% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $2.24M -$1.68M -42.9% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $2.79M -$1.45M -34.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $3.2M -$6.27M -66.2% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $3.57M -$3.97M -52.6% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $3.92M -$4.18M -51.6% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $4.24M -$4.29M -50.3% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $9.47M +$3.92M +70.6% Dec 31, 2019 10-K 2021-03-17
Q3 2019 $7.53M +$2.14M +39.8% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $8.09M +$2.65M +48.6% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $8.53M +$2.8M +48.8% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $5.55M -$50K -0.89% Dec 31, 2018 10-K 2020-03-13
Q3 2018 $5.39M -$107K -1.95% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $5.45M +$120K +2.25% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $5.73M +$674K +13.3% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $5.6M +$601K +12% Dec 31, 2017 10-K 2019-03-13
Q3 2017 $5.5M +$147K +2.75% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $5.33M +$12K +0.23% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $5.06M -$822K -14% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $5M -$508K -9.23% Dec 31, 2016 10-K 2018-03-07
Q3 2016 $5.35M -$492K -8.42% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $5.32M -$132K -2.42% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $5.88M +$670K +12.9% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $5.5M -$1.63M -22.9% Dec 31, 2015 10-K 2017-03-02
Q3 2015 $5.84M -$1.97M -25.2% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $5.45M -$2.56M -32% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $5.21M -$3M -36.5% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $7.14M -$594K -7.68% Dec 31, 2014 10-K 2016-02-17
Q3 2014 $7.82M +$160K +2.09% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 $8.01M +$682K +9.31% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $8.21M +$1.35M +19.6% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 $7.73M +$1.11M +16.8% Dec 31, 2013 10-K 2015-03-12
Q3 2013 $7.66M -$1.01M -11.7% Sep 30, 2013 10-Q 2013-10-30
Q2 2013 $7.32M -$843K -10.3% Jun 30, 2013 10-Q 2013-07-31
Q1 2013 $6.87M -$1.1M -13.8% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 $6.62M -$943K -12.5% Dec 31, 2012 10-K 2014-03-04
Q3 2012 $8.67M +$28K +0.32% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 $8.17M -$1.11M -11.9% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 $7.97M Mar 31, 2012 10-Q 2012-04-20
Q4 2011 $7.56M +$1.36M +22% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $8.64M +$2.28M +35.9% Sep 30, 2011 10-Q 2011-10-25
Q2 2011 $9.27M +$3.21M +52.9% Jun 30, 2011 10-Q 2011-07-28
Q4 2010 $6.2M Dec 31, 2010 10-K 2012-03-08
Q3 2010 $6.35M Sep 30, 2010 10-Q 2010-10-28
Q2 2010 $6.06M Jun 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.